FiercePharma15h
Bayer's rising prostate cancer star Nubeqa crosses blockbuster barrier as Xarelto continues downward descent
Despite generic headwinds to Xarelto and challenges across different sectors of the conglomerate suggesting “twists and turns ...
FiercePharma16h
FDA rejects Intercept's ask for Ocaliva full nod in rare liver disease, but accelerated approval remains
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
FiercePharma20h
StrideMD touts remote patient monitoring tech in National Diabetes Month awareness campaign
As National Diabetes Month gets underway, StrideMD is among the diabetes care providers, tech developers and drugmakers ...
FiercePharma20h
With high hopes for the economy, AstraZeneca adds $2B to US investment in manufacturing, R&D
AstraZeneca on Tuesday revealed that it’s adding $2 billion more to its current outlay in the U.S., representing a total ...
FiercePharma20h
Swiss CDMO Lonza to double its ADC prowess by adding 2 suites, 200 jobs at its Visp site
Swiss CDMO Lonza is bulking up its bioconjugation manufacturing digs with two new multicustomer suites and 200 new jobs at ...
FiercePharma21h
PhRMA TV spot calls on lame-duck Congress to pass PBM reforms, secure savings for patients
PhRMA is pushing to get pharmacy benefit manager (PBM) reform over the line in Congress’ lame-duck session, using its first ...
FiercePharma21h
Future Fields looks to solve industry's biomanufacturing woes with fruit fly-based protein production
With biomanufacturing often a limiting factor for drug developers, Canada’s Future Fields is heralding its bug-based approach ...
FiercePharma23h
Pfizer explores sale of hospital drugs unit amid activist investor’s call for accountability: Reuters
After a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to ...